Loading...
•
Jun 30, 2022
CareDx Q2 2022 Earnings Report
Reported a net loss, but testing volume and patient digital solutions showed momentum.
Key Takeaways
CareDx reported a revenue increase of 9% year-over-year, reaching $80.6 million. The company delivered 45,000 patient test results, a 21% increase compared to Q2 2021. However, the company experienced a net loss of $21.7 million, compared to a net loss of $1.9 million in the same period last year.
Delivered 45,000 patient test results, representing growth of 21% compared to second quarter of 2021
Achieved revenue of $80.6 million, increasing 9% year-over-year
Sustained strong overall GAAP gross margin of 66%
Project to achieve profitable growth with positive adjusted EBITDA by first half of 2023
Revenue by Segment
Forward Guidance
CareDx is revising revenue expectations to be in the range of $325 million to $335 million due to higher than expected mix of commercial patients from the success of new launches and market expansion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...